Download PDF
Thromb Haemost 2012; 107(05): 1003-1005
DOI: 10.1160/TH11-11-0799
Letters to the Editor
Schattauer GmbH

The homozygous p.C1024R-ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in Japan

Fumihiro Taguchi
1   Department of Hematology, Iizuka Hospital, Fukuoka, Japan
,
Hideo Yagi
2   Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
,
Masanori Matsumoto
2   Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
,
Shingo Sadamura
3   Department of Internal medicine, Social Insurance Inatsuki Hospital, Nara, Japan
,
Ayami Isonishi
2   Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
,
Kenji Soejima
4   Chemo-Thero-Therapeutic Institute, Kumamoto, Japan
,
Yoshihiro Fujimura
2   Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
› Author Affiliations Financial support: This work was supported in part by research grants fro the Ministry of Health, Labor, and Welfare of Japan an the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Further Information

Publication History

Received: 16 November 2011

Accepted after minor revision: 05 January 2011

Publication Date:
25 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
    CrossrefPubMedGoogle Scholar
  • 2 Kremer-Hovinga J, Mäder G, Lovey P. et al. A second Swiss family with Upshaw-Schulman syndrome (hereditary thrombotic throbocytopenic purpura, TTP) : Clinical course and molecular findings. J Thromb Haemost. 2005; 03 (Suppl. 01) Abstarct P1139.
    PubMedGoogle Scholar
  • 3 Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010; 91: 1-19.
    CrossrefPubMedGoogle Scholar
  • 4 Hommais A, Rayes J, Houllier A. et al. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Thromb Haemost 2007; 98: 593-599.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Wille-brand factor-cleaving protease. Best Pract Res Clin Haematol 2001; 14: 437-454.
    CrossrefPubMedGoogle Scholar
  • 6 Fujimura Y, Matsumoto M, Isonishi A. et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost 2011; 09: 283-301.
    CrossrefPubMedGoogle Scholar
  • 7 Fujimura Y, Matsumoto M, Yagi H. et al. Von Wille-brand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol 2002; 75: 25-34.
    CrossrefPubMedGoogle Scholar
  • 8 Kato S, Matsumoto M, Matsuyama T. et al. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 2006; 46: 1444-1452.
    CrossrefPubMedGoogle Scholar
  • 9 Yagi H, Ito S, Kato S. et al. Plasma levels of ADAMTS13 antigen determined with an enzyme immunoassay using a neutralizing monoclonal antibody parallel ADAMTS13 activity LevEls. Int J Hematol 2007; 85: 403-407.
    CrossrefPubMedGoogle Scholar
  • 10 Ishizashi H, Yagi H, Matsumoto M. et al. Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndrome. Thromb Res 2007; 120: 381-386.
    CrossrefPubMedGoogle Scholar
  • 11 Tao Z, Anthony K, Peng Y. et al. Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 04: 1931-1935.
    CrossrefPubMedGoogle Scholar
  • 12 Camilleri RS, Cohen H, Mackie IJ. et al. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. J Thromb Haemost 2008; 06: 331-338.
    CrossrefPubMedGoogle Scholar